用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Alprazolam'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页116 条记录, 当前第1/12页。
公开号 公开日 申请号 申请日
1. RU2506073C1 2014/2/10 RU20120138222 2012/9/6
专利标题:METHOD OF TREATING ADAPTATION DISORDERS IN PATIENTS WITH RISK OF SUICIDALITY 法律状态
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to psychiatry, and concerns treating adaptation disorders in patients with a risk of suicidality. That is ensured by determining blood serotonin and melatonin, and if the derived relation is 1.2, an integrated therapy involving drug-induced and psychotherapeutic exposure according to the following procedure is required. Haloperidol 0.375-0.5 mg is administered 3 times a day for two weeks


2. CN103223027A 2013/7/31 CN20131141968 2013/4/22
专利标题:Medicinal preparation for treating and preventing vegetative nerve functional disturbance diseases 法律状态
专利权人WANG GUOEN;


3. CN103204856A 2013/7/17 CN20131127636 2013/4/15
专利标题:Deuterated alprazolam and preparation method thereof 法律状态


4. EP2230911A4 2013/7/3
专利标题:Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs 法律状态
专利权人Zars Pharma, Inc.;


5. ES2403193T3 2013/5/16
专利标题:Composiciones que comprenden alprazolam para el tratamiento del insomnio primario y del insomnio asociado con estados de ansiedad y procedimientos para su preparación 法律状态
专利权人Laboratorios Bago S.a.;
Uso de alprazolam para la preparación de un medicamento destinado al tratamiento del insomnio primario mediante administración sublingual.


6. CN103099944A 2013/5/15 CN2013112845 2013/1/15
专利标题:Drug for treating stubborn insomnia 法律状态
专利权人NANYANG MEDICAL COLLEGE;


7. EP2087893B1 2013/2/13
专利标题:Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and processes for preparing them 法律状态
专利权人Laboratorios Bago S.a.;
Disclosed is a composition comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and the corresponding use and method comprising the administration of alprazolam sublingual tablets having a disintegration time lower than 30 seconds and having the alprazolam preferably in non-crystalline or partially crystalline form according to the X-ray diffraction crystallography expanded for the position delta 9-12.5 (2 theta) to a patient suffering from said disorde...


8. US8277840B2 2012/10/2
专利标题:Sustained release formulation of alprazolam 法律状态
The present invention is directed towards the preparation of extended release Alprazolam formulation. The formulation thus obtained provides an efficient mode of delivery of Alprazolam in a continuous manner.


9. US8168625B2 2012/5/1 US10/559290 2005/12/2
专利标题:Pharmaceutical composition based on agonist of benzodiazepine 法律状态
专利权人Sigma Pharma Ltda.;
The present invention describes the use of pharmaceutical compounds in pharmaceutical compositions for sublingual administration including as active ingredient thereof an agonist of the central receptor of benzodiazepinics chosen among diazepam lorazepam bromazepam triazolam alprazolam flunitrazepam nitrazepam and midazolam maleate in a mixture with a pharmaceutical excipient consisting of at least 70% of the weight of the final formulation containing 40-45% by weight of lactose 15-27% by weight...


10. AU2011218610A1 2011/9/15 AU20110218610 2011/8/26
专利标题:Aerosol and injectable formulations of nanoparticulate benzodiazepine 法律状态
The present invention comprises a nanoparticulate composition comprising (a) a benzodiazepine having an effective average particle size of less than about 2000 nm wherein the benzodiazepine is selected from the group consisting of alprazolam brotizolam chlordiazepoxide clobazam clonazepam clorazepam demoxazepam flumazenil flurazepam halazepam midazolam nordazepam medazepam diazepam nitrazepam oxazepam midazepam prazepam quazepam triazolam temazepam loprazolam pharmaceutically acceptable salts an...



首页123456下页尾页116 条记录, 当前第1/12页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文